Form 4: Albemarle General Counsel Sells 172 Shares
Insider Transaction Report
Albemarle's General Counsel and Secretary, Ander C. Krupa, reported the sale of 172 shares of common stock at $105 per share.
Summary
- Ander C. Krupa, General Counsel & Secretary of Albemarle Corp (ALB), reported an insider transaction.
- The transaction involved the direct sale of 172 shares of Albemarle common stock.
- The sale occurred on October 24, 2025, at a price of $105 per share.
- Following this transaction, Krupa beneficially owns 11,483 shares of common stock directly.
- The sale was executed pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2025, prior to Krupa becoming an Executive Officer.
Sentiment
Score: 5
Explanation: The sale of shares by an insider is a neutral event given it was executed under a pre-arranged Rule 10b5-1 trading plan adopted before the individual became an executive officer, indicating a non-discretionary transaction.
Positives
- The sale was conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled, non-discretionary transaction rather than a reaction to new information.
- The 10b5-1 plan was adopted on March 13, 2025, prior to the reporting person becoming an Executive Officer, further suggesting the sale was not based on recent insider knowledge.
Negatives
- An insider, the General Counsel & Secretary, sold 172 shares of common stock.
Risks
- Insider selling, even if pre-planned, can sometimes be perceived negatively by the market, potentially leading to short-term downward pressure on the stock.
Future Outlook
NA
Industry Context
NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Executive Officer Status | Non-Executive Officer | Ander C. Krupa | Between March 13, 2025, and October 24, 2025 | Change in corporate designation to Executive Officer |
Stakeholder Impact
- Shareholders: May view the insider sale with slight caution, though mitigated by the 10b5-1 plan. The overall impact is likely minimal due to the small number of shares relative to total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 2025-03-13 | Rule 10b5-1 trading plan adopted. |
| 2025-10-24 | Common stock sale transaction date. |
| 2025-10-28 | Form 4 filing signature date. |
Recommendation
holdThe Form 4 reports a routine, pre-scheduled insider sale under a 10b5-1 plan adopted before the individual became an executive officer. This transaction is not indicative of new material information or a change in the company's fundamental outlook, thus it does not warrant a change in investment recommendation based solely on this filing.
Keywords
Albemarle, ALB, insider trading, Form 4, stock sale, Ander C. Krupa, General Counsel, 10b5-1 plan, executive officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.